ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,363Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 680

$923K Total Retail Price of All Prescriptions

Rank: 98 out of 680

621 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 621 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 621 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
ATORVASTATIN CALCIUM 591 530 1 11
CARVEDILOL 572 451 2 23
AMLODIPINE BESYLATE-BENAZEPRIL 526 430 3 43
AMLODIPINE BESYLATE 524 467 4 1
SIMVASTATIN 463 413 5 3
FUROSEMIDE 306 244 6 6
ZOLPIDEM TARTRATE 293 235 7 17
METFORMIN HCL 290 241 8 8
LEVOTHYROXINE SODIUM 272 241 9 2
DIOVAN 267 228 10 31
BENAZEPRIL HCL 264 210 11 40
TRAMADOL HCL 257 248 12 18
OMEPRAZOLE 206 180 13 7
HYDROCODONE-ACETAMINOPHEN 199 150 S3 14 4
LOSARTAN POTASSIUM 169 149 15 21
NEXIUM 155 139 16 16
EXFORGE 145 126 17 151
ALLOPURINOL 133 97 18 33
GABAPENTIN 130 112 19 15
LISINOPRIL 126 103 20 5
LIPITOR 115 102 21 68
NIFEDIPINE ER 111 70 22 75
GLYBURIDE-METFORMIN HCL 110 107 R 23 107
METOPROLOL SUCCINATE 106 93 24 13
DIOVAN HCT 106 94 24 55
LORAZEPAM 104 97 26 125
ALENDRONATE SODIUM 102 102 27 32
RENVELA 102 58 27 222
METOPROLOL TARTRATE 102 90 27 12
NIFEDIAC CC 100 68 30 281
BYSTOLIC 92 85 31 79
CRESTOR 90 89 32 25
CELEBREX 87 81 33 90
TAMSULOSIN HCL 84 67 34 34
HYDROCHLOROTHIAZIDE 82 68 35 9
INSULIN SYRINGE 78 67 36 86
AMOX TR-POTASSIUM CLAVULANATE 74 64 37 124
WARFARIN SODIUM 74 57 37 20
GLIPIZIDE 73 71 39 63
LANTUS 72 58 40 49
FLUOXETINE HCL 70 63 41 74
PREDNISONE 69 58 42 50
CLONIDINE HCL 68 56 43 36
CIPROFLOXACIN HCL 68 56 43 57
ENALAPRIL MALEATE 67 67 45 65
CLOPIDOGREL 65 57 46 26
ESCITALOPRAM OXALATE 63 59 47 45
BENICAR 60 57 48 131
SPIRONOLACTONE 60 53 48 82
NAMENDA 59 58 50 35
SENSIPAR 58 47 51 242
PLAVIX 58 54 51 39
QUETIAPINE FUMARATE 57 41 53 64
CLONAZEPAM 56 52 54 190
LOVASTATIN 51 51 55 44
TRAZODONE HCL 51 40 55 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.